Abstract
ObjectiveThe risk of developing diffuse large B-cell lymphoma (DLBCL) is increased in many rheumatic diseases (RDs). It is possible that RD-associated DLBCL is a distinct subset within the category of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have